VEGFA and glaucoma: Intra vitriol triamcinolone was a promising drug; but was associated with glaucoma and cataract formation.20 Anti-VEGFs have proved effective, claiming better results.21-23 Bolt studies have supported the use of bevacizumab (Avastin; Genentech, San Francisco, CA, USA) as compared to Laser in patients with center-involving CSME without advanced macular ischemia.24 It is to be noted that in anti-VEGF treatment, regular visits, monitoring and repeated injections are necessary.